API Holdings Ltd, PharmEasy`s parent, may also consider a further issue of equity shares via a private placement of up to 12.50 billion rupees, the company said in its draft red herring prospectus.
Indian digital healthcare platform PharmEasy filed for an initial public offering (IPO) on Wednesday of up to 62.50 billion rupees ($842.43 million), becoming the latest startup in the country to pursue a domestic stock listing.
API Holdings Ltd, PharmEasy`s parent, may also consider a further issue of equity shares via a private placement of up to 12.50 billion rupees, the company said in its draft red herring prospectus.
Source :
